Cardiology Letters 2024, 33(4):221-225
Comments on the 2023 ESC Guidelines for the management of cardiomyopathies
- Kardiologická klinika LFUK a NÚSCH, a. s., Oddelenie zlyhávania a transplantácie srdca NÚSCH, a. s., Bratislava, Slovenská republika
Published: April 1, 2024 Show citation
References
- Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503-626.
Go to original source... - Donal E, Delgado V, Bucciarelli-Ducci Ch, Galli E, Haugaa KH, Charron P, et al. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging. Eur Heart J CardiovascImaging 2019;20:1075-1093. Go to original source...
- Lang RM, Badano LP, Mor-Avi V, AfilaloJ, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-271. Go to original source...
- Frey N, Meder B, Katus HA. Left ventricular biopsy in the diagnosis of myocardial diseases. Circulation 2018;137:993-995. Go to original source...
- Wilde AM, Semsarian C, Márquez MF, Shamloo AS, Ackerman MJ, Ashley EA, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace 2022;24:1307-1367. Go to original source...
- Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. Go to original source...
- Amr A, Koelemen J, Reich C, Sedaghat-Hamedani F, Kayvanpour E, Haas J, et al. Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information. Clin Res Cardiol 2024;113:728-736. Go to original source...
- Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J 2014;35:2733-2779. Go to original source...
- DeVries JH, Irs A, Hillege HL. The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients. Eur Heart J 2023;44:3492-3494. Go to original source...
- O´Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al. A novel clinical risk prediction model for suddenn cardiac death in hypertrophic cardiomyopathy (HCM riskSCD). Eur Heart J 2014;35:2010-2020. Go to original source...
- Seferovic PM, Polovina M, Rosano J, Bozkurt B, Metra M, Heymans S, et al. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eut Heart J 2023;23:18991922. Go to original source...
- Mc Donagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023;44:3627-3639. Go to original source...